SMAD7 and colorectal carcinoma: In contrast, mice with a transgenic overexpression of SMAD7 in T cells are protected against tumor development in the model of azoxymethan (AOM) and dextran sodium sulfate (DSS)-induced colitis-associated cancer (CAC) or following the subcutaneous injection of syngenic MC38 CRC cells [68,69].